Odontogenic Tumor Market, by Tumor Type
(Malignant Odontogenic Tumor and Others), by Diagnosis (Computerized Tomography
Scan and Others), by Treatment (Surgery and Others), by End-Users (Dental
Clinics, Hospitals, and Others)– Forecast Till 2023
Regional Analysis
The odontogenic tumor market in the
Americas is expected to dominate the global odontogenic market during the
forecast period owing to the increasing prevalence of odontogenic tumor
diseases along with the growing geriatric population and well-established
healthcare sector in the region. The European market is expected to be the
second-largest due to government funding and support from the healthcare
sector, coupled with increasing research and development. Moreover, the market
in Asia-Pacific is anticipated to be the fastest-growing market during the
forecast period owing to technological developments, an increasing number of
advanced surgeries in emerging economies, and favorable government initiatives
for healthcare facilities. The Middle East and Africa is anticipated to hold
the smallest share of the global odontogenic tumor market. The market growth in
this region can be attributed to the increasing healthcare expenditure and lack
of awareness among the people regarding odontogenic tumor in children.
Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/6381
Key
Players
Some of the key players in the global odontogenic tumor
market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson
Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention
International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec
Corporation, Oral health innovation Ltd, Senior Dental Care, LLC,
and Amerident Dental Inc.
Segmentation
The global odontogenic tumor market is segmented into types of
tumor, diagnosis, treatment, and end-user. Based on types of tumor the
odontogenic tumor market is segmented into two segments, namely, malignant
odontogenic tumors and benign odontogenic tumors. Malignant odontogenic tumors
are further sub-segmented into ameloblastic carcinoma, primary intraosseous
carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic
carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and
odontogenic sarcomas. Benign odontogenic tumors are further segmented into
epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal
origin. Epithelial origin is further sub-segmented into ameloblastoma,
conventional, squamous odontogenic tumor, calcifying epithelial
odontogenic tumor, and adenomatoid odontogenic tumor.
Mixed (Epithelial-Mesenchymal) origin is
further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor,
odontoma, and dentinogenic ghost cell tumor. Mesenchymal origin is further
sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma,
cementoblastoma, and cemento-ossifying fibroma. On the basis of diagnosis,
the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT
scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the
odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy. Based on
end-user, the odontogenic tumor market is further segmented into hospitals,
dental clinics, dental laboratories, dental academics, and research institutes.
Market Highlights
The odontogenic tumor is the
abnormal growth of cells in and around the jaws and teeth. Many of these tumors
are considered to be benign. In usual cases, odontogenic tumors are malignant
means they are likely to spread in jaws and teeth. This tumor can be
diagnosed using different techniques such as computerized
tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy.
The increasing incidence of the
odontogenic tumor and other dental-related diseases, rising geriatric
population, and increasing incidence of children suffering from an odontogenic
tumor and dental clinics are anticipated to drive the growth of the market
during the forecast period. However, unfavorable reimbursement scenario and
lack of awareness among the people regarding odontogenic tumor may hamper the
growth of the market during the assessment period. The global odontogenic tumor
market is dominated by many market players. The key players in the market are
engaged in new launches and strategic collaborations to hold their market
position.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/odontogenic-tumor-market-6381
Browse More Research Reports
at:
Eye
Allergy Treatment Market Size, Application | Share Analysis, 2023
Cardiac
Rehabilitation Devices Market Size, Share Analysis | Growth, 2023
About Market
Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by products,
services, technologies, applications, end users, and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important questions.
In order to
stay updated with technology and work process of the industry, MRFR often plans
& conducts meet with the industry experts and industrial visits for its
research analyst members.
Contact:
Market
Research Future
+1 646 845
9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment